Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/2/13  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Daniel L. Simmons

Wrong Dr. Daniel L. Simmons?


Phone: (801) ***-****  HQ Phone
Local Address:  Utah , United States
Brigham Young University
3326 Harold B. Lee Library
Provo , Utah 84602
United States

Company Description: Founded in 1875, Brigham Young University has grown from a small pioneer academy to one of the world's largest private universities, where more than 29,000 students...   more

Employment History


  • Ph.D.
73 Total References
Web References
BYU's lawsuit said a chemistry professor, ..., 4 May 2012 [cached]
BYU's lawsuit said a chemistry professor, Daniel Simmons, discovered the genetic workings of the drug in the early 1990s. It accused Pfizer of violating a research agreement the school made with predecessor companies.
As part of the settlement, BYU plans to endow a Dan Simmons Chair in recognition of his lifelong work advancing human health.
"We are pleased to resolve this matter and the uncertainty of litigation and to be in a position to support Dr. Simmons' research efforts at BYU," Pfizer said in a brief statement. Neither side would comment further.
In court filings, BYU said it had a research agreement with Monsanto Co., later acquired by Pfizer, for the development of a "super aspirin" - a drug that could reduce pain and inflammation without triggering gastrointestinal effects. Simmons claimed to have discovered an enzyme that caused those side effects, and the new drug works to disable it.
According to BYU, Simmons' research was critical in the development of Celebrex, yet Monsanto and successor companies gave the chemistry professor no credit or compensation.
In court filings, Pfizer claimed it met all of its obligations under the Monsanto agreement. It argued BYU's lawsuit had no merit and that the school and Simmons were trying to capitalize on the commercial success of Celebrex.
Pfizer had claimed that Simmons did not contribute to the development of the drug.
Vioxx case illustrates dual nature of drugs, 23 Dec 2004 [cached]
"This is where it all becomes murky," said Dr. Daniel Simmons, the director of the Cancer Research Center at Brigham Young University and a discoverer of the COX-2 enzyme.
U.S. District Judge Dale Kimball turned ..., 6 Oct 2009 [cached]
U.S. District Judge Dale Kimball turned back a Pfizer motion that claimed it had no confidentiality agreement when BYU professor Daniel L. Simmons shared his research with Monsanto, the predecessor of Pfizer, which later marketed Celebrex.
Simmons, who came to BYU from Harvard in 1989, identified an enzyme that causes inflammation. Other scientists made similar discoveries, but the BYU team was the first to publish its findings.
To turn the discovery into a commercial pain-relief product, BYU and Monsanto worked out an agreement under which Simmons would direct the research and Monsanto would handle the patents. BYU was to share in the profits of any products that resulted.
Instead, the lawsuit alleges, Pfizer used Simmons' research to test a compound patented by another scientist, canceled its contract with BYU and denied the school and its professor any credit or monetary rewards related to Celebrex.
At issue in Kimball's ruling last week was whether a research agreement between BYU and Monsanto was in force when Simmons sent biological materials and information to
Pfizer representatives continued to insist that the allegations by BYU and Simmons are "baseless."
"Pfizer is confident that the facts clearly show that Monsanto fully met all the obligations of its research agreement with BYU and Dr. Simmons."
Pfizer insists Simmons had nothing to do with its blockbuster drug and has a motion before Kimball asking him to rule on that issue.
"We think this year's run is ..., 6 Feb 2007 [cached]
"We think this year's run is going to be the best ever," said Dan Simmons, Director of the Cancer Research Center.
Daniel L. Simmons of ... [cached]
Daniel L. Simmons of Brigham Young University, who discovered the COX- enzyme, is suing Pfizer to be credited with discovery of the technique in that , top breast enlargement, 1608, breast augmentation pictures, tjagc, breast augmentation with fat cost, 0831, free breast enlargement hypnosis, immuar, breast enhancement supplements, oghr, breast augmentation for males, 38592, female breast enlargement exercises, :-D, breast enlargement with birth control pills, dge, breast implant enlargement, 78986, fenugreek for breast enlargement, hmbozl, breast enhancement photo gallery, 155, breast implants houston, :), hormone breast enlargement, zswo, breast growth enhancement, rye, breast enlargement cream do not work, heqf, breast enlargement videos, wgdib, breast implants pictures dd, 174526, big breast enlargement, 560881,
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.